About
Recornea is a clinical-stage medtech ophthalmic company based in Trieste, Italy. Founded in 2019 and relocated from Singapore in 2020, the company specializes in developing innovative therapeutic solutions for eye diseases, particularly corneal shape deformations like keratoconus. Recornea is dedicated to preventing blindness by creating minimally invasive, biocompatible medical devices that restore the physiological shape of the cornea. The flagship product, the GROSSO® Implant, is designed to reshape the cornea in patients with pathological deformations, providing clear clinical outcomes and enhancing surgical procedures for ophthalmologists. Recornea is also developing an implantable filtering device for glaucoma, expanding its offerings in ophthalmology. The company has initiated clinical trials and holds multiple patents for its corneal implant technology, reflecting its commitment to innovation and quality in eye care.
Technologies
Keywords
Company Information
- Employees6
- Founded2019
Location
Trieste, Friuli-Venezia Giulia, Italy
